Is Syros Pharmaceuticals Inc (SYRS) Stock at the Top of the Biotechnology Industry?

A rating of 45 puts Syros Pharmaceuticals Inc (SYRS) near the middle of the Biotechnology industry according to InvestorsObserver. Syros Pharmaceuticals Inc's score of 45 means it scores higher than 45% of stocks in the industry. Syros Pharmaceuticals Inc also received an overall rating of 52, putting it above 52% of all stocks. Biotechnology is ranked 15 out of the 148 industries.

SYRS has an Overall Score of 52. Find out what this means to you and get the rest of the rankings on SYRS!

See Full SYRS Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 52 means the stock is more attractive than 52 percent of stocks. These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Syros Pharmaceuticals Inc Stock Today?

Syros Pharmaceuticals Inc (SYRS) stock is higher by 1.8% while the S&P 500 is lower by -0.73% as of 2:01 PM on Thursday, Oct 6. SYRS is up $0.12 from the previous closing price of $6.68 on volume of 62,659 shares. Over the past year the S&P 500 has fallen -13.93% while SYRS is lower by -84.51%. SYRS lost -$17.31 per share the over the last 12 months. Click Here to get the full Stock Report for Syros Pharmaceuticals Inc stock.